# ClinicalTrials.gov record NCT00805935

> PeptideScanner retained ClinicalTrials.gov record NCT00805935 at 2026-07-30T22:14:20.915Z. Its registry update date was 2012-01-27, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct00805935-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2012-01-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00805935-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00805935-leuprolide-v1.json
- Content SHA-256: `bbed19768d957503cd1074f7674153ac885bbba2694ed7a214ab0bc51c103d1c`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00805935 ([`ctg-observation-nct00805935-2012-01-27-727b8c958905`](#source-ctg-observation-nct00805935-2012-01-27-727b8c958905))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00805935 at 2026-07-30T22:14:20.915Z. Its registry update date was 2012-01-27, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct00805935-2012-01-27-727b8c958905`](#source-ctg-observation-nct00805935-2012-01-27-727b8c958905))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00805935 at 2026-07-30T22:14:20.915Z. Its registry update date was 2012-01-27, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct00805935-2012-01-27-727b8c958905`](#source-ctg-observation-nct00805935-2012-01-27-727b8c958905))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00805935-2012-01-27-727b8c958905`](#source-ctg-observation-nct00805935-2012-01-27-727b8c958905))

## Sources

<a id="source-ctg-observation-nct00805935-2012-01-27-727b8c958905"></a>
- **ClinicalTrials.gov record NCT00805935 · retained source version 2012-01-27:727b8c958905cdb24f744a7aeaed2515609e08c427ee9255ba458cd94f6d4ca4** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00805935) (`ctg-observation-nct00805935-2012-01-27-727b8c958905`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00805935." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00805935-leuprolide-v1.json SHA-256: bbed19768d957503cd1074f7674153ac885bbba2694ed7a214ab0bc51c103d1c.